GOLDEN STATE MEDICAL SUPPLY, INC.

Golden State Medical Supply, Inc. specializes in the manufacturing and supply of sterile pharmaceutical preparations, with deep expertise in tablet and solution formulations for controlled-release and high-demand therapeutic agents. The company consistently delivers complex formulations including solifenacin, venlafaxine HCl, rabeprazole, dextroamphetamine-amphetamine ER, and clobetasol propionate, demonstrating proficiency in GMP-compliant production, batch consistency, and regulatory adherence for federal procurement. Their technical capabilities encompass solid dosage form development, stability testing, and supply chain integrity for Schedule II and III controlled substances, positioning them as a trusted source for mission-critical medications requiring stringent quality controls. The contractor maintains a primary relationship with the Department of Veterans Affairs and the Department of Defense, particularly through DLA Troop Support, supplying essential pharmaceuticals to military and veteran healthcare systems. These agencies rely on the company for long-term, multi-year contracts with option periods, indicating sustained performance and reliability in meeting operational medication needs across VA medical centers and deployed military installations. The business operates under NAICS 325412, focusing on pharmaceutical preparation manufacturing, with supplementary activity in medicinal and botanical manufacturing. This vertical specialization reflects a narrow, high-barrier market position centered on branded and generic drug formulations requiring FDA oversight and DEA registration for controlled substances. The company’s market positioning is that of a niche, high-reliability supplier to federal health and defense logistics networks. As a small business structured as a 2L entity based in Camarillo, California, Golden State Medical Supply, Inc. lacks federal certifications such as 8(a), HUBZone, or WOSB. However, its consistent award history and technical focus on regulated pharmaceuticals underscore its operational maturity and alignment with federal supply chain requirements for secure, compliant drug distribution.